Ads
related to: novavax- Careers
Join our Mission to Improve
the Lives of Patients.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- Sign Up
Sign Up for Updates, News
and Much More.
- About Us
Discover the Unique Approach
That Makes Genmab Different.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- Careers
Search results
Better Buy: Inovio Pharmaceuticals vs. Novavax
The Motley Fool via AOL· 4 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 5 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 4 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via AOL· 2 days agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Novavax (NASDAQ:NVAX) Trading 3.4% Higher
ETF DAILY NEWS· 2 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) shot up 3.4% during trading on Wednesday . 1,132,956 shares changed hands during trading, a decline of 90% from the average session ...
JP Morgan Upgrades Novavax, Inc. (NVAX) to a Neutral from an Underweight – Knox Daily
Knox Daily· 6 days agoNovavax, Inc.’s recently made public that its President, R&D Dubovsky Filip unloaded Company’s shares for reported $0.66 million on May 14 ’24. In the deal valued at $13.90 ...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 6 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 2 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 6 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters via Yahoo Finance· 6 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...